Organization
TriNetX Europe
6 abstracts
Abstract
Impact of use of antibody drug conjugates on the prognostic outcome of patients with HR+ve/HER2-ve MBC: Results from a real world dataset.Org: Mediclinic City Hospital, TriNetX Europe,
Abstract
Fulvestrant and elacestrant utilization on prognostic outcome of patients with HR+ve/HER2-ve MBC.Org: Mediclinic City Hospital, TriNetX Europe,
Abstract
Association between state Medicaid policies and accrual of Black and Hispanic patients to cancer clinical trials.Org: Perelman School of Medicine, University of Pennsylvania, Weill Medical College, Cornell University, Medidata AI,
Abstract
Impact of use of CDK4/6i and neratinib among patients with HER2 +ve MBC: Results from a real world dataset.Org: Mediclinic City Hospital, TriNetX Europe,
Abstract
Use of PARPi among patients with HER2+ve MBC: Results from a real world dataset.Org: Mediclinic City Hospital, TriNetX Europe,
Abstract
Deriving breast cancer chemotherapy patterns from real-world data.Org: Thomas Jefferson University, TriNetX Europe,